Routine testing of Mycoplasma genitalium and Trichomonas vaginalis
- 16 March 2017
- journal article
- research article
- Published by Taylor & Francis in Infectious Diseases
- Vol. 49 (6) , 461-465
Abstract
Background: Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) are common sexual transmitted infections (STI). However, most STI screening programmes do not include routinely detection of these pathogens. Consequently, epidemiological data about MG and TV in the general population is lacking. The current study aims to give insight into the prevalence of both infections, thereby guiding decisions whether testing for these pathogens should be included routinely. Methods: Between February 2013 and August 2015, all samples sent to the laboratory of Diakonessenhuis Utrecht for STI testing (i.e. testing for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)) were additionally examined for the presence of MG and TV by means of a laboratory-developed RT-PCR. Samples were collected by our hospital or by regional general practitioners. Results: A total of 5628 PCR’s were evaluated. In 7.5%, one or more STI were detected. CT was found in 5% and MG was positive in 1.9%. NG was detected in 0.5% and TV was detected in 0.6% of the samples. CT was found more often in primary care than in hospital setting (9.7% vs. 3.0%, p < .05). The same was shown for NG (1.1% vs. 0.2%, p < .05). More men than women were positive for CT (11.2% vs. 3.8%, p < .05) and NG (1.4% vs. 0.3%, p < .05). Conclusion: MG is more prevalent than NG and TV in a regional Dutch population. Furthermore, TV is equally common as NG. Based on our prevalence data, including MG and TV in STI testing protocols should be considered in the future.Keywords
This publication has 14 references indexed in Scilit:
- Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the NetherlandsInternational Journal of STD & AIDS, 2016
- Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine developmentCritical Reviews in Microbiology, 2016
- Trichomonas vaginalis: pathogenicity and potential role in human reproductive failureInfection, 2015
- Epidemiology ofMycoplasma genitaliumin British men and women aged 16–44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)International Journal of Epidemiology, 2015
- Mycoplasma genitaliumInfection and Female Reproductive Tract Disease: A Meta-analysisClinical Infectious Diseases, 2015
- Mycoplasma genitalium: An Emerging Cause of Sexually Transmitted Disease in WomenPLOS Pathogens, 2011
- The Prevalence of Trichomonas vaginalis Infection among Reproductive-Age Women in the United States, 2001-2004Clinical Infectious Diseases, 2007
- Mycoplasma genitalium Among Young Adults in the United States: An Emerging Sexually Transmitted InfectionAmerican Journal of Public Health, 2007
- The Prevalence of Trichomoniasis in Young Adults in the United StatesSexually Transmitted Diseases, 2005
- Trichomonas Vaginalis: A Reemerging PathogenClinical Obstetrics and Gynecology, 1993